Record Details

Decision analytic economic paliperidone ER in relapsing schizophrenic patients in Italy

Farmeconomia

View Archive Info
 
 
Field Value
 
Title Decision analytic economic paliperidone ER in relapsing schizophrenic patients in Italy
 
Creator Berto, Patrizia
Negrini, Cristina
Ferrannini, Luigi
 
Subject Pharmacoeconomics; Health economics
Schizophrenia; Typical antipsychotics; Atypical antipsychotics; Paliperidone ER; Cost-effectiveness analysis
 
Description Schizophrenia, with its typical chronic and relapsing course, is very burdensome, both clinically and economically. Its pharmacological management relies on two main drug classes: the older, or typical, antipsychotics, which are quite effective on positive symptoms, but limited by low tolerability and poor efficacy on negative symptoms, and atypical antipsychotics, which are better tolerated and effective on a wider range of psychotic symptoms. In this article, the authors briefly discuss current management options for patients with schizophrenia and highlight some unmet clinical needs in the field. After outlining the main clinical features shown by paliperidone ER, a novel antipsychotic, in its clinical development program, a decision analytic economic appraisal of its use in relapsing schizophrenic patients in Italy, as compared to the other available atypical antipsychotics, is presented. Under base-case assumption and after applying national costs and tariffs, the model predicts paliperidone ER to be associated with better clinical outcomes, expressed in terms of stable days, and lower costs; this means that paliperidone is dominant over the alternatives, according to the principles of economic evaluation of healthcare technologies. One-way sensitivity analyses conducted on structural and cost parameters indicated robustness of base-case estimates, which remain to be confirmed by “real world” national data.
 
Publisher SEEd Medical Publishers
 
Contributor
 
Date 2008-06-15
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

 
Format application/pdf
 
Identifier https://journals.edizioniseed.it/index.php/FE/article/view/221
10.7175/fe.v9i2.221
 
Source Farmeconomia. Health economics and therapeutic pathways; Vol 9, No 2 (2008); 95-108
2240-256X
 
Language eng
 
Relation https://journals.edizioniseed.it/index.php/FE/article/view/221/210
 
Coverage


 
Rights Copyright (c) 2008 Farmeconomia. Health economics and therapeutic pathways
http://creativecommons.org/licenses/by-nc/4.0